Analogic Corporation (NASDAQ:ALOG) Files An 8-K Results of Operations and Financial Condition
Item2.02 Results of Operations and Financial Condition
On June6, 2017, Analogic Corporation (the Registrant) announced
its financial results for the fiscal quarter ended April30, 2017.
The full text of the press release issued in connection with the
announcement is attached as Exhibit 99.1 to this Current Report
on Form8-K.
The information in this Item2.02 and the Exhibit attached hereto
shall not be deemed filed for purposes of Section18 of the
Securities Exchange Act of 1934 or otherwise subject to the
liabilities of that section, nor shall it be deemed incorporated
by reference in any filing under the Securities Act of 1933 or
the Securities Exchange Act of 1934, except as expressly set
forth by specific reference in such a filing.
Item9.01 Financial Statements and Exhibits
| (d) | Exhibits |
|
Exhibit No. |
Description |
|
| 99.1 | Press Release dated June 6, 2017 |
About Analogic Corporation (NASDAQ:ALOG)
Analogic Corporation designs, manufactures and commercializes guidance, diagnostic imaging and threat detection technologies. The Company operates through three segments: Medical Imaging, Ultrasound, and Security and Detection. The Company’s Medical Imaging segment provides medical imaging systems and subsystems for computed tomography (CT), magnetic resonance imaging (MRI) and high-resolution digital mammography. The Company’s Ultrasound business segment provides ultrasound procedure guidance systems for the urology and surgery markets. The Company’s Security and Detection segment designs and manufactures automated threat detection systems for aviation baggage inspection applications utilizing medical CT technology and systems used for deoxyribonucleic acid (DNA) analysis for law enforcement and government agencies.
